---
run_id: halo-evidence-vs-diagnosis-validation-v12-vanilla-long-prompt-03
created: 2026-05-24
eval_type: contradiction-preservation
case_id: halo-evidence-vs-diagnosis-validation-v12
benchmark_version: halo-evidence-vs-diagnosis-validation-v12-v1
model_condition: vanilla_long_prompt
run_number: 3
model_name: gemma-4-31b-it-mlx:2
model_id: gemma-4-31b-it-mlx:2
model_snapshot: LM Studio MLX 8-bit model id lmstudio-community/gemma-4-31B-it-MLX-8bit; loaded_context_length 65536
runtime: LM Studio local OpenAI-compatible HTTP server; MLX runtime
provider: local
temperature: 0.7
top_p: 0.9
num_ctx: 65536
max_tokens: 2048
seed: 304
prompt_source: condition packet (vanilla_long_prompt) - frozen added material plus frozen Advisor prompt; see run-packet.md
prompt_sha256: 81621976eaf302301d88434e895bffe7f264ddbe9d86bbb0dd82120c2f65f2aa
source_packet: a neutral equal-length filler plus transition, then the frozen Advisor prompt; no substrate artifact - see run-packet.md
source_packet_sha256: 98ca8c241ae7ac2a811e9012d1dcc7202739138b0b2a830b3ed8ef5ba847b45e
condition_packet_sha256: 98ca8c241ae7ac2a811e9012d1dcc7202739138b0b2a830b3ed8ef5ba847b45e
output_file: model-outputs/vanilla_long_prompt-03.md
judge_model_id: pending - judge receipts recorded separately under judge-packet
judge_prompt_sha256: pending - judge receipts recorded separately under judge-packet
judge_independence: pending - judge receipts recorded separately under judge-packet
raw_model_output_public_safe: true
---

# Model Output - vanilla_long_prompt (run 03)

## Condition

Benchmark version `halo-evidence-vs-diagnosis-validation-v12-v1`, condition `vanilla_long_prompt`, run 3 of 8. Real local-model run: `gemma-4-31b-it-mlx:2` via lmstudio, seed 304, on the frozen condition packet.

## Output

**Recommendation:** Run the **Case Evidence Review**.

**Why:** Your current success is "entangled" and potentially illusory. The strong quarter is heavily skewed by temporary pricing bundles (financial incentive) and roadmap promises (future hope), rather than current product value. More concerning is the usage data: high frequency is driven by managers reviewing *closed* samples (non-productive work) and analysts abandoning the tool after two days or failing to explain it to reviewers (workflow failure). You do not have a scaling problem; you have a fundamental "value-gap" problem. The Case Evidence Review is the only option that diagnoses *why* analysts are falling back to manual notes and *where* the logic breaks down for reviewers, providing the necessary evidence to fix the product before you scale a leaky bucket.

**Strongest Reason Against:** This is a qualitative, slow-motion discovery process that does not provide the immediate "hard" financial validation the board may want before locking the budget. Unlike the Demand Cleanroom, it doesn't test price elasticity or immediate revenue risk; unlike the Adoption Quality Sprint, it doesn't provide a real-time dashboard. It risks delaying a "scale" decision while the sales team is currently riding a wave of momentum.

**Observable Evidence to Change My Mind:** If the **Demand Cleanroom** were to reveal that expansion bookings remain high and renewal cycles stay short *even without* the bundle pricing and roadmap pitches, it would prove that customers are buying based on current perceived value rather than financial incentives. In that scenario, the risk shifts from "product failure" to "growth optimization," making a quantitative validation sprint or scaling more attractive.
